MedTrace Logo

MACCS: Multicenter Australian CE in Patients With Suspected Crohn's Disease Study

NCT00434551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2019-07-31

No results posted yet for this study

Summary

This is a prospective study aimed to validate the ability of capsule endoscopy to accurately diagnose small bowel Crohn's disease in symptomatic patients who have a non-diagnostic standard workup. Patients will be randomized to undergo capsule endoscopy either one week or five weeks after enrolment. Patients will be followed up for up to 3 months after capsule endoscopy.

Conditions

  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • Medtronic - MITG

    lead INDUSTRY

Principal Investigators

  • Warwick Selby, MD · Royal Prince Alfred Hospital, Sydney, Australia

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2007-12-31
Completion
2008-02-29

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00434551 on ClinicalTrials.gov